As of July 16, about 8.9 million kids ages 12 to 17 had received Pfizer’s vaccine in the U.S. The CDC received 9,246 reports of adverse events after vaccination among this age group, just 9.3 percent of which involved serious adverse events such as myocarditis (4.3 percent).
Among about 129,000 U.S. adolescents participating in a smartphone-based vaccine safety surveillance system, 63.4 percent reported local reactions after getting the shot, and 48.9 percent reported systemic reactions. Systemic reactions were more common after the second dose.
The Advisory Committee on Immunization Practices conducted a risk-benefit assessment and continues to recommend the Pfizer-BioNTech COVID-19 vaccine for all persons over 12 years old, the CDC said.
To view the full report, click here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.